Global News

ClinPharm Consulting changes name to Kinetigen

Monday, February 4, 2013 11:26 AM

ClinPharm Consulting, a specialty pharmaceutical consulting firm with global reach, has changed its name to Kinetigen. All management, scientific and operational components of Kinetigen remain the same as under ClinPharm, including the consulting firm’s focus on clinical pharmacology and pharmacokinetics.

More... »

Solvias acquires Confarma

Monday, February 4, 2013 10:55 AM

Pharmaceutical service provider Solvias  has acquired Confarma, a global provider of scientific services, and its subsidiary Confarma France. The acquisition is a key component of the forward-looking growth strategy of Solvias and Confarma.

More... »

Chiltern wins PharmaTimes award

Monday, February 4, 2013 10:23 AM

Chiltern International, a global CRO, has won an award at the PharmaTimes Annual Awards 2012. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

More... »

The Medicines Company, Alnylam develop RNAi therapeutics for hypercholesterolemia

Monday, February 4, 2013 09:51 AM

The Medicines Company, a global pharmaceutical company, and Alnylam Pharmaceuticals, an RNAi therapeutics company, have formed an exclusive global alliance for the development and commercialization of Alnylam's ALN-PCS RNAi therapeutic program targeting PCSK9 for the treatment of hypercholesterolemia.

More... »

Icon to acquire clinical trial services division of Cross Country Healthcare

Monday, February 4, 2013 09:14 AM

Icon, a global provider of outsourced development services, has agreed to acquire the clinical trial services division of Cross Country Healthcare, a healthcare staffing and outsourcing services company, for a cash consideration of $52 million, plus an earn-out of up to $3.75 million related to certain performance-based milestones. The transaction is expected to close within the next 30 days. 

More... »

Novo Nordisk promotes four to senior vice president

Friday, February 1, 2013 02:39 PM

Novo Nordisk, a global healthcare company, has promoted four corporate vice presidents to senior vice presidents. Effective March 1, 2013, the following members of the U.S. executive team will assume the title of senior vice president in their respective areas: Andy Ajello, U.S. national diabetes sales; Camille Lee, U.S. diabetes marketing; Alan Moses, MD, global chief medical officer; and Anne Phillips, MD, U.S. clinical, medical and regulatory affairs.

More... »

Foresite closes $100M growth capital fund for late-stage healthcare companies

Friday, February 1, 2013 02:12 PM

Foresite Capital Management, a growth equity firm founded by Jim Tananbaum to finance late-stage healthcare companies, has closed its $100 million fund, Foresite Capital Fund I. The firm draws on Tananbaum and his partners' experience and expertise in building leading healthcare companies, as well as their broad private and public investment experience.

More... »

Elan sells remaining stake in Alkermes

Friday, February 1, 2013 01:43 PM

Following the close of trading today, Elan’s wholly-owned subsidiary, Elan Science Three, agreed to sell, on customary terms, all of its remaining 7,750,000 ordinary shares of Alkermes through Jefferies & Company pursuant to Rule 144 under the U.S. Securities Act of 1933. The sale is expected to close on February 6, 2013.

More... »

Life Technologies establishes international influenza network

Friday, February 1, 2013 01:14 PM

Life Technologies, a global biotechnology company, has established the Global Influenza Network, a partnership including scientists at a number of the world's leading government public health organizations, veterinary agencies and research institutes in a collaborative effort to increase the speed and efficiency of influenza monitoring and vaccine development.

More... »

The CenterWatch Monthly, February 2013

Friday, February 1, 2013 10:48 AM

Sized out of big deals, mid-tier CROs still thriving

More... »